The Importance of Dose Escalation in the Treatment of Pulmonary Arterial Hypertension with Treprostinil

<b>Background</b>: Treprostinil, which is administered via continuous subcutaneous or intravenous infusion, is a medication applied in the treatment of pulmonary arterial hypertension (PAH). The dose of treprostinil is adjusted on an individual basis for each patient. A number of factors...

詳細記述

書誌詳細

出版年:	Biomedicines
主要な著者:	Piotr Kędzierski, Marta Banaszkiewicz, Michał Florczyk, Michał Piłka, Rafał Mańczak, Maria Wieteska-Miłek, Piotr Szwed, Krzysztof Kasperowicz, Katarzyna Wrona, Szymon Darocha, Adam Torbicki, Marcin Kurzyna
フォーマット:	論文
言語:	英語
出版事項:	MDPI AG 2025-01-01
主題:	pulmonary arterial hypertension prostacyclin treprostinil dose escalation respond to treatment
オンライン･アクセス:	https://www.mdpi.com/2227-9059/13/1/172